Pharmaceutical Preparations · DE · CIK 2081043
AtaiBeckley Inc. develops psychedelic-based neuroplastogens for difficult-to-treat mental health conditions
Comparable business profile · signals at a glance
In the 90 days to Mar 20, 2026: 2 sold $509K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Craig Kevin JamesChief Medical Officer | Sell | 100,000 | $3.55 | $355K |
| Jan 2, 2026 | Feilding-Mellen CosmoDirector | Sell | 39,594 | $3.90 | $154K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.